Halle Berry

Berry's investing is a recent, focused second act built around health problems she has lived through. Undiagnosed for a decade in perimenopause and managing type 2 diabetes, she backs and often joins companies serving underserved health markets, women's midlife health above all. She founded Respin, invested in and became an executive at microbiome company Pendulum, backed intimate-health brand Joylux and was the largest individual investor in canned-wine startup Bev. The track record is thin and mostly post-2022, and she has been candid that convincing largely male VCs that menopause was a real market was hard.